Sian Yik Lim, MD
Rheumatology · Aiea, HINPI 1992092225
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $867 of the $1,314 with a category attached, or 66.0%. 6 manufacturers reported payments, led by Amgen at 39.5% of the total. Reporting peaked in 2022 at $396 and has fallen 50.3% since, to $197 in 2023. That places this record below the midpoint for rheumatology clinicians in HI, where the typical reported total is $1,399.
Across 29 payments — averaging $45.32 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$520
- Pfizer$328
- GSK$230
- Cardinal Health 110 LLC$200
- Novartis$20
- AbbVie$17
What the payments were for
- Consulting fees$43033%
- Food & beverage$86766%
- Education$171%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$1,314 in reported general payments places this provider in the 45th percentile of 21 rheumatology providers in Hawaii.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| KrystexxaPegloticase | 43 | $1,251,586 |
| Enbrel MiniEtanercept | 59 | $442,268 |
| Enbrel SureclickEtanercept | 38 | $285,198 |
| Xeljanz XrTofacitinib Citrate | 48 | $279,027 |
| RinvoqUpadacitinib | 22 | $184,858 |
| Humira(Cf) PenAdalimumab | 23 | $165,754 |
| ProliaDenosumab | 78 | $137,320 |
| EnbrelEtanercept | 13 | $94,023 |
| Cosentyx (2 Syringes)Secukinumab | 11 | $79,707 |
| Taltz AutoinjectorIxekizumab | 11 | $74,359 |
| TymlosAbaloparatide | 16 | $41,981 |
| BenlystaBelimumab | 11 | $41,690 |
| Amjevita(Cf) AutoinjectorAdalimumab-Atto | 12 | $36,677 |
| Leflunomide | 470 | $34,265 |
| Teriparatide | 11 | $28,659 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AmgenKrystexxa, Prolia, Enbrel | $520 | $1,482,929134 claims |
| AbbVieRinvoq | $17 | $184,85822 claims |
| NovartisCosentyx (2 Syringes) | $20 | $79,70711 claims |
| GSKBenlysta | $230 | $41,69011 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 45th percentile of 21 rheumatology providers in Hawaii.
Other rheumatology in Aiea
- Scott KawamotoHonolulu$58K
- Daniel BrandtHonolulu$29K
- Kristine UramotoHonolulu$26K
- Deryll AmbrocioHonolulu$21K
- Mari ShiraishiHonolulu$9K
- Devy SetyonoHonolulu$9K
- Sadao JinnoHonolulu$6K
- Heejae JungHonolulu$4K
- Denny NakayamaHonolulu$3K
- Ken ArakawaHonolulu$3K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.